Rachel M. Squillace
Ariadne Diagnostics (United States)(US)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology, Lung Cancer Research Studies, Estrogen and related hormone effects
Most-Cited Works
- → Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway(2009)395 cited
- → The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models(2016)321 cited
- → mTOR-Raptor Binds and Activates SGK1 to Regulate p27 Phosphorylation(2008)261 cited
- → α7 Integrin Mediates Cell Adhesion and Migration on Specific Laminin Isoforms(1996)117 cited
- → Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling(2015)115 cited
- → Ridaforolimus (AP23573; MK-8669), a Potent mTOR Inhibitor, Has Broad Antitumor Activity and Can Be Optimally Administered Using Intermittent Dosing Regimens(2011)105 cited
- → Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations(2015)86 cited
- → Fragment Growing and Linking Lead to Novel Nanomolar Lactate Dehydrogenase Inhibitors(2013)84 cited
- → Inhibition of Muscle Differentiation by the Novel Muscleblind-Related Protein CHCR(2002)67 cited
- → The evolutionarily conserved TSC/Rheb pathway activates Notch in tuberous sclerosis complex and Drosophila external sensory organ development(2010)62 cited